Healthcare Boss: Jason A. Duprat Speaks with Lamassu CEO Dr. Gabi Hanna MD About Navigating Intellectual Property & Entrepreneurship

03/30/2020

Dr. Gabi Hanna, a physician entrepreneur with more than 15 years of leadership experience in early drug development and the Executive Director at Duke Preclinical Translational Research Unit speaks with Jason A. Duprat, Entrepreneur, Healthcare Practitioner and Host of the Healthcare Entrepreneur Academy Podcast. In this episode, they talk about the field of translational research. Dr. Hanna offers advice to entrepreneurs interested in navigating entrepreneurship while working for another institution.

CLICK HERE to listen to Jason Duprat and Gabi Hanna’s conversation on Healthcare Boss.

READ MORE

06/06/2025

Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development of a novel treatment protocol for acute pancreatitis in canines....

READ THE ARTICLE
06/04/2025

Cleveland Business Journal: Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds

Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for dogs with acute pancreatitis. The therapeutic, called RABI-767, also could...

READ THE ARTICLE
04/08/2025

The Washington Times: Biotech should take a page from Elon Musk’s playbookThe Washington Post:

Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve. Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless...

READ THE ARTICLE